Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruibao Ren

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
MSC-Derived Apoptotic Vesicles Restore Bone Marrow Niche Homeostasis in Postmenopausal Osteoporosis by miRNA-Mediated Suppression of MAPK and NF-κB Signaling NodesZhiwen Tu, Haolin Wu, Youxi Jiang, et al.
Blood|June 7, 2003
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML developmentJason A Wertheim, Samanthi A Perera, Daniel A Hammer, et al.
Cell Death Discovery|December 12, 2023
A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signalingNannan Ning, Ziqi Shang, Zhiping Liu, et al.
Frontiers of Medicine|July 31, 2021
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemiaXiao Huang, Tingting Ma, Yongmei Zhu, et al.
Blood|March 22, 2007
Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signalingMing Yan, Jiann-Kae Luo, Kenneth J Ritchie, et al.
International Journal of Biological Sciences|June 16, 2023
Synergism of FAK and ROS1 inhibitors in the treatment of <i>CDH1</i>-deficient cancers mediated by FAK-YAP signalingJiaming Gao, Yunying Yao, Chenxuan Liu, et al.
BMC Cancer|August 21, 2019
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm studyXiaoyang Li, Yuexin Dong, Ya Li, et al.
Frontiers of Medicine|April 15, 2021
DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesisXiuli Zhang, Zhizhou Xia, Xingyu Lv, et al.
Journal of Hematology & Oncology|June 20, 2020
Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibitionXinhua Xiao, Ping Liu, Donghe Li, et al.
Journal of Hematology & Oncology|July 4, 2021
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemiaPeihong Wang, Xinhua Xiao, Yuyin Zhang, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
MSC-Derived Apoptotic Vesicles Restore Bone Marrow Niche Homeostasis in Postmenopausal Osteoporosis by miRNA-Mediated Suppression of MAPK and NF-κB Signaling NodesZhiwen Tu, Haolin Wu, Youxi Jiang, et al.
Blood|June 7, 2003
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML developmentJason A Wertheim, Samanthi A Perera, Daniel A Hammer, et al.
Cell Death Discovery|December 12, 2023
A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signalingNannan Ning, Ziqi Shang, Zhiping Liu, et al.
Frontiers of Medicine|July 31, 2021
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemiaXiao Huang, Tingting Ma, Yongmei Zhu, et al.
Blood|March 22, 2007
Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signalingMing Yan, Jiann-Kae Luo, Kenneth J Ritchie, et al.
International Journal of Biological Sciences|June 16, 2023
Synergism of FAK and ROS1 inhibitors in the treatment of <i>CDH1</i>-deficient cancers mediated by FAK-YAP signalingJiaming Gao, Yunying Yao, Chenxuan Liu, et al.
BMC Cancer|August 21, 2019
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm studyXiaoyang Li, Yuexin Dong, Ya Li, et al.
Frontiers of Medicine|April 15, 2021
DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesisXiuli Zhang, Zhizhou Xia, Xingyu Lv, et al.
Journal of Hematology & Oncology|June 20, 2020
Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibitionXinhua Xiao, Ping Liu, Donghe Li, et al.
Journal of Hematology & Oncology|July 4, 2021
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemiaPeihong Wang, Xinhua Xiao, Yuyin Zhang, et al.
Pageof 7